Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00349011 · ClinicalTrials.gov registry record · NA
Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00349011: Completed NA study, sponsored by Yale University.
NCT00349011 is a NA study that has completed, run by Yale University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00349011, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of a personalized menopausal therapy risk assessment and genetic counseling intervention on knowledge, risk perception, and decision-making in healthy women at increased risk for breast cancer.
Interventions
- PROCEDURE Personalized risk assessment
- PROCEDURE genetic counseling intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2002-08 |
| Est. Completion | 2004-03 |
| Phase | NA |
What the finished NCT00349011 record still lists
NCT00349011 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Personalized risk assessment is the first listed.
NCT00349011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00349011 about?
NCT00349011 is a clinical study titled "Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer". The purpose of this study is to determine the effects of a personalized menopausal therapy risk assessment and genetic counseling intervention on knowledge, risk perception, and decision-making in healthy women at increased risk for breast cancer.
What is the current status of trial NCT00349011?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2002-08. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00349011?
The interventions under investigation include: Personalized risk assessment (PROCEDURE), genetic counseling intervention (PROCEDURE).
Who is sponsoring clinical trial NCT00349011?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00349011's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia